Olympus Partners Acquires PAI Pharma
February 24, 2025
Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.
- Buyers
- Olympus Partners
- Targets
- PAI Pharma
- Sellers
- Enhanced Healthcare Partners, Bourne Partners Strategic Capital
- Industry
- Pharmaceuticals
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.